24/4/22
Applications open
Menu
Roche & Start-Up Nation Central share the vision of enhanced digital health support for Alzheimer’s disease patients and their caregivers. We strive to identify innovative solutions that will make a difference in patients’ lives, enabling prevention, early detection, intervention & monitoring. This is why we founded the “Roche for a better future: Alzheimer’s Innovation Challenge”
Please note: Applications are now closed.
startups made it to the global showcase event
Alzheimer’s disease (AD) is the most common form of dementia, a term used to describe different brain disorders that affect memory, thinking, behavior and emotion. There are currently estimated to be over 55 million people worldwide living with dementia with significant social and economic consequences.
There is a growing recognition that the process of Alzheimer’s disease begins many years prior to clinically obvious symptoms. Thus the ultimate goal of identifying individuals in the preclinical stages of Alzheimer disease with less invasive, faster and more effective methods, is to facilitate early intervention to delay the clinical syndrome, promote early and optimal management, optimize physical health, cognition, activity and wellbeing.
Ideal functionality:
*You may apply even if your solution does not meet all these functions
Should be self-administered by individuals ideally in the remote environment (e.g. at home). Ready to market solution – an advantage
The solution should be non-invasive
The solution ideally provides advanced analytics calculating a risk score for diagnosis/monitoring
Is ideally based on a daily life device (e.g. smartphone), and does not require proprietary hardware
Advantage: the solution interfaces with and can be connected to medical information systems via FHIR standards.
Applications open
Informational webinar with Roche
Roche is a global pioneer in pharmaceuticals and diagnostics and the world’s largest biotech company, focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics, as well as growing capabilities in the area of data-driven medical insights help Roche deliver truly personalized healthcare.
In Roche, innovation has always been about identifying and seizing opportunities. Despite the great medical progress, there is still a huge need and a growing demand for specific diagnostics and better tolerated therapies. Going forward, Roche intends to again increase its investment in research and development.
For more information, please visit
www.roche.com
Start-Up Nation Central is the address for corporations, governments and investors to connect with the Israeli tech ecosystem. We catalyze growth opportunities by bringing Israeli tech innovation to global business and societal challenges. Established in 2013 and headquartered in Tel-Aviv, Israel, Start-Up Nation Central is a not-for-profit organization funded by philanthropy.
For more information, please visit
www.startupnationcentral.org
RoX Health is a Startup Studio rooted in Roche, based in Berlin, Germany. We turn ideas into healthcare businesses and encourage greater initiative in the healthcare industry. Currently, we focus on certain topics in oncology, neurology and women’s health
For more information, please visit
https://roxhealth.com
Roche & Start-Up Nation Central share the vision of enhanced digital health support for Alzheimer’s Disease patients and their caregivers. The challenge strives to identify innovative solutions that will make a difference in patients’ lives, enabling prevention, early detection, intervention & monitoring. An advantage will be given to digital health solutions that support early detection of Alzheimer’s Disease.
This challenge is not equity nor investment focused.
The Challenge is open to privately held companies formed and registered under the laws of Israel with a company ID (חפ), or technology transfer offices/entities of non-profit and/or governmental entities (such as universities, hospitals and sick funds) (“TTO/s”), which develop a project/solution that may answer the competition challenge, and who have applied for patent protection underlying the technology subject of such project/solution.
We welcome solutions with a Technology Readiness Level (TRL) of 5 and above.
English will be the official language.
The challenge will have both online and physical/hybrid presence, which will be communicated in advance (depending on COVID-19 situation and MoH guidelines).
For the meeting with the Advisory Committee & the Pitch, one person will be required to pitch the startup and solution. It is important to have a team member that can address all questions from the advisory committee members.
For the Mentoring meetings, we advise at least two team members of your startup, one business-oriented and another more tech-oriented to be able to cover all types of conversations in the 1-on-1 sessions.
If your startup is pre-selected after the online applications, you’ll be invited to:
If your startup is the winner, you will receive a 100K NIS grant from Roche Israel and you’ll be invited to:
The selection process will be managed by an Advisory Committee with representatives from local AD medical experts, Roche AD global team, ROX and Almeda Ventures. The committee will be focusing on your product (ready to market – an advantage), team, market, business model and unique value proposition.
Yes, definitely. You can apply with as many projects you believe would fit and benefit with the challenge. Each startup will require its own application.
Roche Pharmaceuticals (Israel) Ltd. All rights reserved © 2022
Roche Pharmaceuticals (Israel) Ltd. All rights reserved © 2023
The intention of a System Check is to assess in detail how ready a company is to bring a digital health solution to the German healthcare market & EU. During the System Check, our experts from various backgrounds such as IT, regulatory, finance, commercialization, medicine, market access and product look at the information provided by the startup company. Based on the available information we compile a detailed assessment that is shared in a 1-1 session with the startup.